Company intelligence
Sonas Pharma
Innovative ECS medicines for the future.
Biotechnology Research
Belfast, GB
2 employees
3 public signals
About Sonas Pharma
Developing innovative ECS medicines to treat epilepsy and obesity.
Verified activity
Signals from Sonas Pharma
3 published signals
Products & Services
Sonas Pharma Emma Cheetham is building SNS-101 against the bar for orphan paediatric epilepsy.
Reported by Chris Hayes
Research & Knowledge
Sonas Pharma announced that the SNS-101 series is a deliberately engineered molecule aimed at a specific problem in paediatric epilepsy.
Reported by Chris Hayes
Products & Services
Sonas Pharma introduced precision changes to alter cannabinoid molecule behavior in the body with LGS as its lead indication.
Reported by Chris Hayes